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1.  Introduction 
Preventive health care is at the heart of many suggested reforms to control costs and improve the efficiency of health 
care. While preventive care obviously cannot eliminate death, it can help to extend life and avoid or delay the 
occurrence of diseases. Making decisions about using preventive care, however, can be very difficult. Individuals 
typically know little about the magnitude of the risk that they face and about the potential benefits of preventive care. 
This paper examines the choices that people make about using preventive care, focusing on individuals'  
perceptions of probabilities of disease and death and of the effectiveness of interventions. The risk that an individual 
perceives can be broken down into two components: true risk and bias. While unobserved risk factors prevent 
separating these two components, our data permit us to address the following three questions. First we compare 
perceptions of risk to individually predicted risk based on epidemiological models. While the epidemiological 
models do not represent true risk for all individuals, they are an objective measure of risk and if averaged across 
individuals should be close proxies to the average true risk. Second we investigate whether individuals risk 
perceptions are influenced by their risk factors.  Do individuals whose risk factors indicate higher risk, such as high 
blood pressure or diabetes, report higher subjective probabilities?  Finally we consider the effect of risk perceptions 
on the use of preventive care.  Individuals who perceive greater risk are expected to be more likely to use preventive 
care. 
Careful consideration of risk factors and epidemiologically predicted risk is important to understanding 
behavior.  While, economists have acknowledged the importance of risk perceptions, many continue to consider 
externally estimated probabilities rather than subjective probabilities.  Our paper is unique in that we consider both. 
This allows us to address which are better predictors of behavior.  
There are several key differences between the previous literature and the present paper. First, we measure 
individuals’ perceptions of risk in the form of subjective, numerical probabilities. Numerical probabilities not only 
have more predictive power than more qualitative expectations data (Juster, 1966), but also allow better evaluation of 
the internal consistency and external validity of responses. Second, while the previous literature has primarily 
focused on a single intervention, we consider multiple preventive care measures for each individual. This allows us 
to analyze behavioral differences across preventive interventions. Third, we compare the effects of subjective and 
individually predicted epidemiological risks on behavior, for a general population sample that is not limited to the 
elderly population. Fourth, we explore several survey methods of eliciting subjective estimates of risk. 
We find that a majority of respondents answer probability questions in a way consistent with basic 
probability concepts. Moreover, they appear to be aware of some of the qualitative relationships between risk factors 
and probabilities. However, on average, they have very poor perceptions of the absolute probability levels as reported 
in the epidemiological literature. Perceptions are less accurate if a respondent is female and has no college degree 
and the accuracy of perceptions deteriorates after age 50. Nevertheless, perceived probabilities strongly affect the 
subsequent take-up rate of flu shots, mammograms, Pap smears, sexually transmitted disease testing, and aspirin for 
the prevention of heart disease. Our results indicate that probability perceptions are key to understanding behavior 
regarding preventive care and designing effective preventive health care programs. 3 
The paper proceeds as follows. Section 2 discusses literature on preventive health care and subjective 
probabilities. Section 3 describes the institutional details of preventive care programs in the Netherlands. Our survey 
and data collection are described in section 4. Section 5 considers the epidemiological literature on the relevant 
probabilities of disease and death. Section 6 presents our empirical results and section 7 concludes. 
 
2.  Preventive Health Care and Subjective Probabilities 
From an economic perspective the decision to take up preventive care is an investment decision. Loosely speaking, 
such an investment is worthwhile if the expected present value of the reduction in illness and the probability of death 
is greater than the opportunity costs of the intervention; see, Grossman (1972), Cropper (1977), Hey and Patel 
(1983), Dardanoni and Wagstaff (1987 and 1990), Selden (1993), Chang (1996), and Byrne and Thompson (2001) 
for formalizations of these notions. 
Whether people ultimately decide to invest in preventive care is largely an empirical matter. We mention a 
selection from the large empirical literature. Kenkel (1994) finds that the probability that women will have 
mammograms and Pap smears increases with schooling and insurance coverage and decreases with age. Mullahy 
(1999) finds that schooling and insurance coverage are important determinants of getting a flu shot. The 
interpretation of the effects of insurance coverage may reflect price effects, access to health care in general, or some 
' adverse'  selection (people with a high demand for health care are more likely to have insurance). Wu (2003) finds 
that self reported health, fear, and expectations for the future influence the use of preventive care.  Belkar et al. 
(2006) suggest that awareness plays a key role in determining who uses preventive care and that failing to account 
for this awareness can influence the measurement of other effects. Trivedi et al. (2008) find that co-pays also play an 
important role. Insurance companies that introduce co-pays for mammograms see decreases in the percentage of 
women participating in these interventions. 
Central in any analysis of preventive health care are the probabilities of illness and death and the 
effectiveness of prevention. Typically, these parameters are assumed to be known by the individual. However, 
individuals’ perceptions of the risks they face may differ widely from the true underlying risks and thus perceptions 
are likely to be better predictors of individual behavior. 
We measure perceptions using subjective probabilities. The measurement of subjective probabilities in 
economics was first proposed by Juster (1966). The standard question takes the form: "What is the percent chance 
that you will choose X" or that "X will happen”. Juster shows the superior informational content of such probabilities 
over qualitative response scales (like “very likely”, “probable”, “rarely”) when trying to predict consumer choice. 
Since the early 1990s, such subjective probabilities have become an integral part of major household surveys around 
the world. Their validity and predictive power has been shown in a wide range of contexts, including retirement 
behavior (Hurd and McGarry, 1995), bequests (Hurd and Smith, 2002), income expectations (Dominitz and Manski, 
1997), contraceptive choice (Delavande, 2008), individual survival (Hurd and McGarry, 2002 and Gan, Hurd and 
McFadden, 2003), health risks of smoking (Khwaja, Silverman and Sloan, 2009), and life events of adolescents 
(Bruine de Bruin et al., 2007). 
The existing literature that examines the relationship between risk perception and the use of preventive care 
has typically used qualitative risk perceptions and samples of limited size. Salant et al. (2006), for example, find that 4 
33 women who are objectively assessed to be at high risk for breast cancer are unlikely to feel that they are at high 
risk and are skeptical of the effectiveness of prevention. Lipkus et al. (2000) find that information on both absolute 
risk and relative risks are necessary to encourage participation in prevention. Satterfield et al. (2000) consider the 
relationship between perceived risks and behaviors in the case of osteoporosis. They find that people who are more 
informed about recommendations regarding various preventive behaviors are more likely to follow those 
recommendations. They also asked about risk using categorical responses but did not relate that to behavior. Finally, 
Peters et al. (2006a) examine the relationship between worry, risk perceptions, and intentions to reduce medical 
errors in a small convenience sample. They find that worry matters more than risk perceptions, but focus on 
intentions to act (not on actual behavior) and use categorical representations of risk (not numerical subjective 
probabilities).  
Our paper differs from these in several important ways.  First, we use numerical subjective probabilities.  
Second, we relate these subjective probabilities to objective probabilities predicted by epidemiological models.  
Third, our sample size, 5,686, is significantly larger than previous studies.  Fourth, each individual is asked about 
multiple preventive care interventions. 
 
3.  The Dutch Flu Shot and Mammogram Program 
The Netherlands has mandatory health insurance for all residents. Each person is required to purchase a basic health 
insurance package from a private insurance company.
1 Individuals have the opportunity to change insurance 
companies at the beginning of each year, which discourages insurance companies from investing in prevention.  
While the minimum contents of the basic health insurance package are mandated by law, preventive care programs 
are currently not included. It is possible to buy supplementary insurance that covers additional services not covered 
by the basic insurance package. ￿
Instead, the Dutch government funds some preventive care through the National Institute of Public Health 
and the Environment (RIVM). Preventive care, in the case of cancer screening can be expected to have benefits long 
after a one-year insurance contract ends and, in the case of influenza vaccines, has significant public health benefits. 
This paper considers three of the most important preventive care measures available through the RIVM to adults in 
the Netherlands: flu shots, mammograms and Pap smears.
2  
First, the RIVM provides influenza vaccines for everyone over the age of 60 (65 before 2008) and to certain 
high risk groups.  In a typical year, roughly 5 to 20 percent of the population can be expected to catch influenza (or 
the flu).
3  For most people symptoms last 1 to 2 weeks.  However for the elderly (ages 60 and up) and at risk 
populations, such as those with heart disease, pulmonary problems, or diabetes, influenza can lead to death.  
Mortality due to influenza for the elderly is approximately 130 per 100,000 people, 100 times mortality due to 
influenza for adults under the age of 50; see Thompson et al. (2003). Each year influenza vaccines are developed to 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
1 Basic insurance is subsidized for low income households and insurance companies must accept all applicants. 
￿￿Other common preventive care measures, such as colonoscopies and Prostate-Specific Antigen (PSA) tests are not 
currently provided on a systematic basis either through the basic insurance packages or through the RIVM.￿
￿￿By flu, we mean actual flu or influenza, not a cold or stomach flu.  Symptoms of influenza include rapid onset, 
aching muscles all over the body, a high temperature and usually a pounding headache. ￿5 
prevent the strains of influenza expected to be most likely in the coming year.  Through the RIVM' s program, general 
practitioners send letters in the fall to all of their patients who are eligible for these free flu shots inviting them to 
come in for their flu shot.  Outside of this age range people can still receive a flu shot from their doctor.  In this case 
the out-of-pocket price will depend on their specific health insurance package. 
Second, to increase the chances of identifying breast cancer at an early stage, the RIVM provides 
mammograms to women between the ages 50 and 75.  One in ten Dutch women will get breast cancer at some point 
in their life.  Important risk factors for breast cancer include current age, age that menstruation began, age of first live 
birth, the number of relatives who had breast cancer, and the number of past breast biopsies.  Annual mammograms 
can reduce the probability of death from breast cancer by 15 percent; see Gotzsche and Nielsen (2006). The RIVM 
funds mammograms every two years for women between the ages of 50 and 75, which leads to a slightly lower 
decrease in the probability of death.  Women receive a letter from the RIVM directly inviting them to have a 
mammogram.  Women outside of this age group may still receive mammograms, but the out-of-pocket price will 
depend on their specific insurance package. 
We also consider Pap smears which are provided every five years to women between the ages of 30 and 60. 
According to a recent article in the New England Journal of Medicine,
4 Pap smears are one of the most effective 
preventive care interventions available. Annual Pap smears can reduce cervical cancer mortality by at least 94%. 
Early detection of benign abnormalities can even prevent cells from becoming cancerous. In the Netherlands, Pap 
smears are given once every five years. At this frequency, mortality can be reduced by 83%. As with mammograms, 
women receive a letter from the RIVM directly inviting them to schedule an appointment for a free Pap smear with 
their general practitioner. In the case of Pap smears, women may be able to receive Pap smears more often or before 
reaching age 30; the price will depend on their insurance. 
In addition to these three publicly funded prevention programs, we consider two other preventive care 
measures. These provide an interesting contrast to the government funded programs because of the different 
incentives for individuals to use them, including the fact that they may not need to see a doctor.
5 The first is daily 
low dose aspirin for the prevention of cardiovascular disease. Low dose aspirin has been shown to promote both the 
primary and secondary prevention of cardiovascular disease, preventing both the development of cardiovascular 
disease and negative outcomes such as heart attacks and strokes. Second, we consider screening for sexually 
transmitted diseases (STD) among individuals under the age of 40.  In some larger cities, young adults received 
invitations for STD screening, although receipt of these invitations is less systematic in the case of flu shots, 
mammograms and Pap smears.  These preventive care interventions provide three intervention opportunities for men 
and five for women. 
 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
4 Sawaya et al. (2001). 
5 It is recommended that people begin daily low dose aspirin after speaking with their doctor, however given the 
prominence of this intervention in the media; it is possible that some people would choose to begin such therapy on 
their own. 6 
4.  The Survey 
Our primary data source is the LISS Panel, a random representative sample of Dutch individuals who participate in 
monthly Internet surveys.
6 It contains information on a large variety of domains including demographics, housing, 
work and time use, happiness and health, and financial decisions. The LISS Panel has two important advantages that 
make it particularly valuable for this research.  First, it is possible to randomize the content and format of questions, 
for example to compare the effects of different wordings of questions.  Second, it is possible to follow up with the 
same participants at a later date. 
The largest part of the data used in this paper was collected in September 2008. Panel members were asked 
additional questions in January 2009. In the initial survey, respondents were asked a series of questions mainly on 
past take up of flu shots, mammograms, Pap smears, use of aspirin, and sexually transmitted disease screening, and 
various related perceived probabilities. The text of the subjective probability questions is available in Appendix 
Table 1.  All respondents receive questions about influenza and heart disease.  Only women receive questions about 
mammograms and Pap smears.  Questions about sexually transmitted diseases are only asked to those under 40.  
Previous research on the elicitation of subjective probabilities shows that survey modes can affect responses; see e.g. 
Woloshin et al. (2000). We therefore use three different survey modes, randomly assigned to respondents: an open-
ended probability question, (with a number between 0 and 100 to be typed in), a linear probability scale (with a 
number between 0 and 100 to be selected using the mouse) or the linear probability scale with magnifier (magnifying 
a part of the scale around the cursor location). The second two response modes use a visual scale on the screen 
allowing respondents to select their answer on a number line.  With the magnifier, respondents see a number line 
similar to the linear scale, but when they click on the line with their mouse they see a magnified section allowing 
them to choose a number with more precision. These three response modes result in similar mean response across 
questions, however the visual scales reduce the use of focal responses such as 0, 50 and 100 and the use of multiples 
of 10 in general.  These scales do not significantly change our results and are discussed in more detail in a 
companion paper: Bruine de Bruin and Carman (2010). Following the Survey of Economic Expectations, we 
introduce the subjective probability questions with a brief description of probabilities; see Manski (2004).
7  
In addition, individuals’ numeracy and ' probability literacy'  were assessed following Peters et al. (2006b). 
Individuals were randomly assigned to receive this numeracy assessment at the beginning or the end of the survey. In 
addition, we asked individuals who had had flu shots, mammograms or Pap smears about their monetary and time 
costs related to the use of prevention. For those who did not participate, we asked about their expected monetary and 
time costs. Monetary costs included both the cost of the intervention and any travel costs. We also asked a number of 
questions that might provide information about people' s motivations for participating or not participating in 
preventive care.  Individuals were asked whether someone they knew well had died of influenza or breast cancer.  
This question was intended to identify whether personal experience with a disease increases an individual' s 
perception of their risk or their likelihood of participation. In January 2009 respondents were approached again, and 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
6 Those who do not have access to the internet are provided with a simple, easy to use computer (a SimPC) and 
internet access. 
7 The text of the subjective probability questions is included in Appendix Table 1. The full survey is available from 
lissdata.nl. The survey is labeled 33 Disease Prevention. 7 
asked whether they had received a flu shot in October 2008 or thereafter. Both in September and January, individuals 
were asked to consider actual influenza, as defined in footnote 3.  
Table 1 reports a number of descriptive statistics, including basic demographics, use of care, and expected 
costs and time to use care. Almost one quarter of respondents received a flu shot in the preceding year, nearly 40% of 
women have had a mammogram in the past two years, and 60% have had a Pap smear in the past 5 years. 
Participation rates are even higher among age groups that are targeted to receive these interventions.   
 
5.  Epidemiological Measures of Health Risks 
Using epidemiological results we imputed each respondent’s individual risk of developing various diseases and of 
dying from those diseases based on their own reported risk factors.  For many diseases, including breast cancer and 
heart disease, there are risk prediction calculators based on epidemiological research available on the internet.  
Individuals can answer questions about their risk factors and receive predictions about their risk of developing 
various diseases; see http://www.yourdiseaserisk.com for an example. While these online calculators often only 
provide relative risk information in qualitative terms, such as “well below average”, “below average”, “average”, 
“above average”, “well above average” risk, there is a statistical model behind these calculators that can be used to 
calculate a numerical risk level. 
Perhaps the most famous risk calculator is the Framingham Risk Assessment tool,
8 which can be used to 
calculate your risk of developing heart disease. This model was developed using the Framingham Heart Study data. 
This study empanelled much of the population of Framingham, Massachusetts and has followed this population and 
their offspring for over 50 years. Using this data, it was possible to identify risk factors that were correlated with the 
five year probability of developing heart disease.
9 The Framingham Risk Assessment tool calculates individual risk 
as a function of age, gender, blood pressure, total cholesterol, and whether the individual is a smoker. 
Another famous risk calculator is the Gail Model (Gail et al., 1989), which can be used to calculate a 
woman' s risk of developing breast cancer.  This model used the Breast Cancer Detection Demonstration Project to 
identify risk factors that predict the probability of developing breast cancer in the next five years.  Important risk 
factors for breast cancer include current age, age that menstruation began, age of first live birth, the number of 
relatives who had breast cancer, and the number of past breast biopsies. Given an individual' s underlying risk for 
developing breast cancer, we can also calculate the individual' s probability of dying from breast cancer in the next 
five, ten or twenty years, with and without annual mammograms. This is a function of the individual' s risk of 
developing the disease and the age specific survival probabilities. Age specific survival rates from the Surveillance 
Epidemiology and End Results (SEER) database were used.  The Gail Model was developed using a population who 
received annual mammograms.  Annual mammograms have been found to cut the risk of death by 15 percent; see 
Gotzsche and Nielsen (2006). The Gail Model has been validated numerous times, both in the US and Europe, and 
has been shown to be a good predictor of risk; see, for example, Rockhill et al. (2001), Decarli et al. (2006), and 
Thomsen et al. (2002). We choose this model because of its prominence and because most risk factors could be 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
8 Wilson et al. (1998) 
9 Ten year probabilities are roughly equivalent to two times the five year probability. 8 
identified in our survey data.  Other risk factors, such as breast density or genetic markers (such as BCR1 and 
BCR2), may be important predictors of risk but few women would be able to accurately report information on these 
factors in survey data. 
For influenza, the epidemiological literature calculating the risk of influenza and death from influenza is less 
precise. The primary problem is that it is very difficult to measure influenza rates in the population.  Many people 
who report having the flu, actually have a cold or a stomach virus and not influenza, and many people who have 
influenza never report it to doctors.  Influenza can be detected with blood tests or using nasal specimens.  We were 
unable to find a study that calculates influenza risk as a function of any risk factors. However, we were able to find 
the average mortality rate by age groups due to influenza for the 1990-1991 through 1998-1999 seasons.  We use this 
measure as the probability of dying from the flu.  Because of the difficulties associated with identifying influenza, 
and because many influenza related deaths can be reported to be due to other co-morbidities, there are three measures 
of the influenza death rate.  The first and most conservative measure counts only laboratory confirmed influenza 
deaths.  The second measure adds deaths attributed to respiratory and circulatory problems that are influenza related.  
The third and most liberal measure includes all causes of death that can be attributed to influenza.  Table 2 shows the 
annual mortality rates by age used for our predicted risk of death as calculated by Thompson et al. (2003).  Mortality 
rates increase dramatically with age, for both the liberal and the conservative estimates; individuals over the age of 
65 are one hundred times more likely to die from influenza than individuals between the ages of 5 and 49.  Of course, 
the actual risks associated with influenza evolve as a smooth function of age. 
The most liberal estimates of the death rate from influenza have been used historically by many studies.  
However, these results are based on increases in all causes of death for people who have influenza.  If a person who 
has influenza or has recently had influenza dies in a car accident this could be counted as an all-cause influenza 
related death.  The most conservative estimates underestimate the mortality rate due to influenza, since influenza is 
more fatal for people who have co-morbidities such as respiratory or circulatory health problems and the cause of 
these deaths may be reported as respiratory.  Therefore the moderate estimate of the death rate is our preferred 
estimate. 
Similar epidemiological models for cervical cancer and STDs are not available.  In particular, it is important 
that risk factors can be easily measured in a survey.  Both cervical cancer risk and STD risks are highly dependent on 
detailed information about sexual behaviors, such as number of partners and use of condoms.  These sensitive issues 
were considered, by the survey agency, to be inappropriate for our survey.  Thus we are not able to compare 
subjective and epidemiological risks for these diseases.  But we will look at the impact of risk perceptions on take up. 
The epidemiological estimates come from a variety of sources, including population observations and 
randomized clinical trials.  These probabilities may deviate from individual probabilities in the field, both because of 
heterogeneity in risk factors not accounted for in the epidemiological models, and behavioral responses to preventive 
interventions. In addition, these studies typically come from US data, while there could be some differences in the 
risk of disease in the Netherlands relative to the US, the epidemiological models will provide a good approximation 
of the level of risk and the relationship between risk factors and risk. 
 9 
6.  Empirical Results 
6.1 Discrepancies between Epidemiologically Predicted and Perceived Probabilities 
The data described in the previous two sections allow us to compare individuals'  perception of risk to their risk as 
predicted by epidemiological models. As described in section 5, for each individual in our sample we calculate their 
individual-specific epidemiological risks using all available sample information on the respondent’s risk factors. 
There are two possible reasons for discrepancies between the epidemiologically predicted risks and perceived risks. 
First, individuals might misperceive their true risk. Secondly, individuals may have information about additional risk 
factors unaccounted for in the epidemiological predictions. However, this would be unlikely to cause a difference 
between the mean (or medians) of the two distributions of probabilities. 
Tables 3 and 4 present these comparisons of the distributions of perceived and predicted epidemiological 
risks. For influenza we see that people report a high likelihood of getting the flu without a flu shot, the mean 
subjective probability of getting the flu in the coming flu season is 31%; the median is lower at 21%.  With a flu shot 
these numbers drop to 20% and 10% respectively.  These numbers are higher than we might expect; in a typical flu 
season less 20% of the population gets influenza; see Hueston and Benich (2004) and Govaert et al. (1998).  One 
possible explanation for this overestimate is that people often use the word flu to refer to other illnesses.  While we 
do state at the beginning of the survey that we are interested in actual influenza and provide a definition, some people 
may not realize the distinction. 
The mean subjective probability of getting breast cancer in 5 years is 19% and is 22% in ten years.  Again 
these amounts are higher than the medians, at 10% and 14%, respectively.  More striking is the difference between 
the subjective probabilities and those found using the Gail Model.  The Gail Model implies that the average risk of 
being diagnosed with breast cancer in the next 5 years is approximately 1%, and 1.9% in ten years.  Perhaps, some of 
this overestimation of risk is due to a prominent public service message in the Netherlands which stated that 1 in 10 
women would get breast cancer in their lifetime. 
The mean subjective probability of getting heart disease in 5 years is 16% and is 19% in ten years.  Again 
these amounts are higher than the medians, both around 10%.  As with influenza and breast cancer, individuals 
overestimate the risk of heart disease, however the overestimation is not as great.  According to the Framingham 
model, the mean risk is 6.4% in 5 years, and doubles in 10 years. There may be less overestimation of the risk of 
heart disease because the epidemiological risks are not as small.  As will be discussed below, individuals have a 
tendency to overestimate very small probabilities more, but this overestimation is less extreme with more moderate 
probabilities.  We also present summary statistics for perception of risk of cervical cancer, and sexually transmitted 
diseases, although similar epidemiological models are not available. 
Table 4 examines the subjective probability of dying from each of the various diseases.  For influenza 
related deaths individuals were asked to report the probability of death if they were to get influenza; combining this 
with their subjective risk of getting the flu we can calculate the unconditional probability of dying from the flu.  
Table 4A reports the unconditional probabilities.  Death from influenza, even for the elderly, is a very rare 
occurrence; the highest epidemiological predictions indicate that mean objective probability of death from influenza 
in a given year in our sample is 0.044% without a flu shot and 0.009% with a flu shot, more than 100 times less than 
the mean reported subjective probabilities (13.24% and 11.14% respectively).  Similarly for breast cancer (Table 10 
4B), the average subjective probabilities of death are about than 100 times those predicted by the epidemiological 
models.  Again with heart disease (Table 4C), individual overestimate their risk of death less than with influenza and 
breast cancer. 
The discrepancies between the two sets of probabilities are in line with previous research on probability 
perceptions in the health domain. Overestimation of health risks has been found for breast cancer (Skinner, 1998), 
and smoking-induced lung cancer (Viscusi, 1992). Bruine de Bruin et al. (2007) find that teenagers vastly 
overestimate the probability of death. As discussed above, these discrepancies in means are likely to be due to 
misperception rather than heterogeneity in individual risks. 
For both influenza and breast cancer we also can compare the effectiveness of the prevention with the 
perceived effectiveness of the intervention.  To do this we calculate the percentage reduction in risk of death due to 
using prevention: (pwo-pw)/pwo, with pwo and pw the probabilities of death without and with the preventive intervention, 
respectively.  Again individuals’ perceptions deviate from the epidemiologically predicted risk reduction.  Here there 
is more variation, partially due to the fact that some people report higher probabilities of death with preventive care 
than without it. While this may seem irrational, it would not be surprising if some individuals actually feel this way. 
One possible explanation might be significant media attention to the sudden death of several people in Israel 
immediately after receiving a flu shot in 2006, which led to a postponement of the vaccination program in the 
Netherlands.  In addition, many people do not trust vaccinations and fear that the live virus in the vaccination will 
cause them to get influenza. 
It is conceivable that the subjective probability distributions are different for respondents with high 
probability literacy. We therefore also inspected the distributions for the subsample of respondents who answered at 
least 10 out the 11 numeracy questions correctly. The average subjective probabilities for this subsample of highly 
numerate respondents are slightly lower than for the total sample, but not enough to change the conclusion that 
people dramatically overestimate the probabilities.
10 
 
6.2 Explaining Perceived Probabilities 
In this section, we examine the factors that predict perceptions of risk. First, we compare the impact of 
epidemiological risk factors as predicted by those models to the impact of the same risk factors on perceptions of 
risk.  Second, we present a regression illustrating which characteristics are most predictive of perceptions of risk.  
These first two methods will allow us to address whether known risk factors impact perceptions of risk or whether 
other factors that should not directly impact risk play a role.  Finally, we consider whether there is a general tendency 
to overestimate risks, and whether some respondents are more likely to consistently overestimate risks. 
As a first pass, we compare epidemiological risks broken down by risk factors to perceived risks broken 
down by the same risk factors.  For influenza risk, we can only consider age as a risk factor.  The last column of 
Table 2 presents the perception of risk of death from influenza by age.  Here we can compare the epidemiologically 
predicted increase in risk as people age to the perceptions.  We can see that perceptions of risk increase with age.  
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
10 Using an alternative definition of numeracy based on consistency of probability answers – P(T<t1) should be 
smaller than P(T<t2) for t1 < t2 – gives similar results. 11 
But in all age groups perceived risks are higher than the risks in even the most liberal model by several orders of 
magnitude.  However, individuals underestimate the relative increase in risk that comes with age.  The 
epidemiologically measured risk of death between the age of 50 and 64 is 8.3 times the risk of death under the age of 
50, but perceived risks increase by only a factor of 1.3.  Comparing the oldest to the middle aged, epidemiological 
risk increases by a factor of 10, but perceived risks increase only by a factor of 1.75. 
For breast cancer and heart disease, we regress epidemiological and perceived risk only on the risk factors 
included in the epidemiological models.  We compare regressions where the dependent variable is the subjective 
probability to regressions where the dependent variable is the epidemiologically predicted probability.  This allows 
us to see whether the respondents are aware of the risk factors that are used to predict the epidemiological 
probabilities and whether their responses reflect the magnitudes of the risks associated with each risk factor. 
Table 5A considers the natural log of breast cancer risk.  In this case, the epidemiological model uses a 
multiplicative formula.  The epidemiological model fits perfectly because it is the exact formula we use to predict 
risks.  Each risk factor (or interaction in some cases) is assigned a different relative risk value. For some risk factors, 
such as age at first birth, different values are assigned for different ranges of ages.  We include dummies for each 
possible value. The coefficients in the epidemiological model indicate the relative impact of each specific risk 
category.  The only risk factor that even comes close to having a similar impact on perceived and epidemiological 
risks is a family history of breast cancer.  In this model, age of first birth is interacted with family history.  However, 
age of first birth has no significant impact among those with no family history and there is no significant difference 
between the coefficient for age at first birth among those with a family history of breast cancer.  Previous biopsies do 
not influence risk perceptions.  For some ages, age does influence risk perceptions, but the magnitudes of the effects 
are significantly different from those predicted in the epidemiological model.  At the oldest ages, women actually 
perceive that the risk of getting breast cancer declines.  This may be because the free program in the Netherlands 
only covers women up to age 75.  This is primarily due to the fact that while the risk of cancer does not decline, the 
risk of death due to cancer does decline due to competing risks. 
Tables 5B and 5C consider heart disease risk separately for men and women.  In this case, the 
epidemiological model is predicted using a discrete table, which was originally based on a multiplicative formula. 
The epidemiological model does not fit perfectly in this case because we use the discrete table to predict risks, rather 
than the precise formula used by the original epidemiological model.  We separate men and women in order to match 
the epidemiological models.  These models are calculated by assigning each individual a number of points based on 
their risk factors.  For example, diabetes adds 4 points for men and 2 points for women, while smoking adds 2 points 
for both men and women.  We use the points assigned for each risk factor as the independent variables in our model.  
In the epidemiological model, we would expect the coefficients on the points for each risk factor to be the same, 
because the number of points added reflects the relative risk associated with that risk factor.  An additional point 
raises the relative risk by approximately 23 percent for men and 14 percent for women in the epidemiological 
models. 
Among women, in Table 5B, we see higher perceived relative risks associated with almost all risk factors: 
age, high blood pressure, cholesterol, and diabetes, but not smoking.  But the marginal effect of additional risk points 
for some risk factors differs significantly from those predicted by the epidemiological model.  Women underestimate 12 
the impact of aging and diabetes.  They overestimate the effect of cholesterol and approximately correctly estimate 
the effect of high blood pressure.  We find no significant effect due to smoking, perhaps because perceptions of risk 
also affect the decision to smoke.  Men, as shown in Table 5C, perceive a higher level of risk as they age, and if they 
have high blood pressure, but we find no significant effect of cholesterol, diabetes or smoking.  The coefficients on 
age and high blood pressure are not statistically significantly different than those in the epidemiological models.   
These three tables suggest that individuals misperceive their risks, as their perceptions only very partially 
respond to risk factors.  However, in all three tables, it is important to point out that these effects are averages.  The 
fit of the models is poor, with R
2 ranging from .02 to .11.  This suggests that there is quite a bit of variation that is 
unexplained by the risk factors from the epidemiological models. Therefore, we turn to a more complete model that 
allows us to investigate what other factors are correlated with risk perceptions.  The epidemiological models that we 
use do not necessarily reflect all possible risk factors and certainly don’t control for cognitive skills that may affect 
the assessment of risk.  For example they don’t control for education which may directly affect both true risks and 
risk perceptions. 
Table 6 presents a broader model of risk perceptions.  Column 1 considers the risk of death from influenza, 
column 2 the risk of heart disease in 5 years, and column 3 the risk of breast cancer in 5 years among women.  Rather 
than focusing on the epidemiological models, here we include not only the epidemiological risk factors but also 
income, education, numeracy and dummies for the visual scales that were randomized across respondents. We again 
see that risk factors do in some cases play a role in forming perceptions of risk.  Most of the results regarding risk 
factors mirror those in Table 5.  Men perceive higher risk of heart disease, although only 1.1% higher than women.  
Age is perceived to increase the risk of heart disease and death from influenza, but not the risk of breast cancer.  As 
in Table 5, we see that many risk factors that should influence risk do not.  Diabetes, high blood pressure, high 
cholesterol and smoking do not affect the perceived risk of death from influenza.  Similarly, diabetes does not affect 
the perceived risk of heart disease, although high blood pressure, high cholesterol and smoking do.  For breast 
cancer, again only past family history of breast cancer influences perceived risks.  Better self assessed health does 
decrease the perceived risk of all three diseases and BMI increases the perceived risk death from influenza and heart 
disease, suggesting that individuals respond to some private information that is not included in the epidemiological 
models.   
These regressions also control for socio-economic characteristics including income and education.  There 
may be direct relationship between actual risk and socio economic status (SES); those with better SES may actually 
enjoy better health.  However there may also be an effect if SES is correlated with ability to answer subjective 
probability questions.  We see that for heart disease, those with higher income report lower risks.  Education does not 
exhibit the same relationship.  The excluded category is those who have completed secondary education.  We see that 
higher education does reduce the perceived risk of death from influenza, but lower education reduces the perceived 
risk of heart disease and breast cancer.  We also control for numeracy, and find that numeracy reduces the perceived 
risk of death from influenza and heart disease.  Those who are more able to answer standard numeracy questions 
report lower probabilities.  While this may suggest a correlation between ability and health, it is more likely that 
those who are more numerate are less likely to dramatically overstate the probability of disease.   13 
Two other pieces of these regressions strongly suggest that the differences between perceived probabilities 
and epidemiological probabilities are driven by misperceptions of risk not by unobserved differences in true risk.  
First, the randomized visual scale treatments actually increase reported probabilities; since these treatments are 
randomized this can not reflect an underlying health difference.  Second, the constants in all three regressions are 
quite large, all around 18%, again highlighting the fact that the average values of the perceived risks are much too 
high to be a reflection only of additional information.  Similarly the magnitudes of the coefficients on age in the 
regressions predicting death from influenza are simply too large to reflect reality.  For example, individuals aged 75 
to 79 perceive their risk of death from influenza to be 18 percentage points higher than those under 24; if perceived 
probabilities just reflect that individuals have more information than the epidemiological models, we would expect 
more than 18 percent of individuals between 75 and 79 to die of influenza each year.  Taken all together, these results 
suggest that individuals tend to dramatically overestimate the risks that they face. 
Thus we turn to a measure that will allow us to estimate the general tendency to overestimate risks.  A 
useful tool to measure discrepancies between perceived and epidemiologically predicted risks is the probability 
weighting function described in Prelec (1998).  Using this weighting function, it is possible to summarize an 
individual’s general tendency to overestimate health risks in a single number.  This function takes the following 
form: 
 
(1)  w(p)= exp[-(-ln p)
￿] 
 
Here w(p) is the perceived probability and p is the actual probability.  The parameter ￿ is a summary measure of the 
degree of bias.  If ￿=1 there is no bias, w(p)=p; if ￿=0 the function is similar to a step function with all underlying 
probabilities being reported at the same value. Given that we have multiple observations of perceived and 
epidemiological probabilities for each individual in our sample), we can estimate individual-specific values of ￿.
11 
We estimate the ￿’s as the coefficient on ln[- ln(p)] in individual specific regressions (without a constant) where ln[-
ln(w(p))] is the dependent variable. Figure 1 shows the shape of the probability weighting function for various values 
of ￿’s, including the median of our estimates (￿=0.50), the 25
th percentile (￿=0.21), and the 75
th percentile, (￿=0.75).  
Lower values of ￿ indicate that small probabilities are overweighted more, higher values of ￿ indicate that small 
probabilities are overweighted less. 
Table 7 reports a regression that describes the relationship between these estimated individual values of a 
and a number of observed respondent characteristics. Higher values of ￿, indicating less over-estimation of small 
probabilities, are associated with higher income, numeracy, college education, and with being male.  Being in 
excellent or good health is also associated with higher values of ￿.  This may occur for two reasons.  First, poor 
health may be associated with higher actual risk than predicted by the epidemiological models.  Thus, individuals’ 
assessments of their own risk may accurately be higher than the epidemiological prediction, leading to lower alphas 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
11 Our estimates are based on the risk of dying from influenza, with and without a flu shot, the risk of getting breast 
cancer, the risk of dying of breast cancer, with and without mammograms over 10 and 20 years, the risk of 
developing heart disease, and the risk of dying of heart disease, with and without aspirin over 10 and 20 years. 14 
for those in poor health.  Second, good health may be a proxy for numeracy and literacy, leading to higher alphas for 
those in good health. Receiving an invitation for a flu shot, leads to lower levels of ￿, and thus more overestimation 
of risks.  This may occur because the invitations alert people to the importance of receiving a flu shot and make the 
risks more salient. Risk factors either have no significant effect on alpha or increase overestimation of risks.  Since 
epidemiological risks already adjust for these risk factors, this likely represents an overestimation of risks. 
The results in this section point to an overwhelming tendency to overestimate risks above and beyond what 
can be explained by characteristics unobserved in epidemiological models.  However overestimation of risks does 
not necessarily imply that risk perceptions affect behavior.  In the next section we turn to the impact of risk 
perceptions on individual behavior. 
 
6.3 The Take-Up of Preventive Care 
This section examines the effect of risk perceptions on the use of preventive care.  First we look at flu shots and 
aspirin, which can be measured for our whole sample.  Then we turn to mammograms, Pap smears, and STD tests 
which can only be measured for subsets of our sample.  Finally, we consider what happens if we jointly control for 
perceived and epidemiological risks.  This allows us to measure whether risk perceptions influence behavior, holding 
risk factors or objective measures of risk constant. 
The first two columns of Table 8A report regressions explaining flu shot take up in the fall of 2007 and after 
September 2008. It is important to note that in column 2, the information on the explanatory variables, notably the 
various perceived probabilities, come from the September 2008 survey, while the dependent variable, flu shot take-
up, comes from the January 2009 survey. This makes it implausible that the results are driven by a justifications bias. 
While justification bias could play a role in the relationship between past flu shot take-up and current perceived 
probabilities (e.g. reporting low probabilities to justify not having a flu shot previously), it is highly  unlikely to play 
a role in this case (e.g. having a flu shot in October 2008 to justify the high probabilities answered in September 
2008).  The results for 2007 and 2008 flu shots are very similar, suggesting that justification bias is not driving our 
results regarding previous use of preventive care. 
The subjective probabilities pwo and pw jointly represent the perceived level of risk as well as the perceived 
effectiveness of the intervention. We choose to use pwo as a measure of the level of risk and (pwo-pw)/pwo as a measure 
of the effectiveness of the intervention. This relative difference is often the form in which the results from 
epidemiological studies on intervention effectiveness are expressed. An additional benefit is that this measure is 
more comparable across individuals; an absolute change in risk of 5 percentage points has a very different 
implication when the perceived risk without intervention is 5% than when it is 95%.
12 Despite the fact that 
individuals overestimate their risk of disease, the effects of perceived probabilities are large and significant. For 
example, the coefficient on our measure of perceived effectiveness, (pwo-pw)/pwo, implies that if the flu shot reduces 
risk by 10% (for example from 25% without a flu shot to 22.5% with a flu shot), take-up would increase by 1.6 
percentage points. Individuals who perceive that flu shots increase the chance of influenza are 3.6 percentage points 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
12 At the same time, regression results could be sensitive to the particular nonlinear transformation that is used. 
Robustness checks – including ones that use  (pwo-pw)  as effectiveness measure – do not change our results, however.   15 
less likely to receive a flu shot, although this effect is only significant in the regression that looks at future use of flu 
shots.  The effectiveness of flu shots at preventing death and the risk of death without a flu shot also increase take up.  
Finally, a 10 percentage point increase in the level of the perceived risk of influenza without a flu shot, pwo, increases 
take-up by 1.4 percentage points. 
A very large effect is found for the invitation to receive a flu shot, which increases take-up by 32 percentage 
points. In addition to the effect of receiving the invitation (which partly depends on age), we find a strong separate 
positive age effect, although these results are suppressed in the table. Additional effects are also found for people 
with diabetes, heart disease, and high blood pressure, risk factors that increase the risk of severe complications. We 
find that having a college degree lowers the probability of flu shot take-up. One explanation is that the higher 
educated have higher opportunity costs of time.
13 Alternatively, they may be in better health which lowers the 
rationale for getting a flu shot.  
Column 3 of Table 8A, considers the use of aspirin for the prevention of heart disease.  The impact of 
perceived risks and effectiveness are smaller than those found with influenza.  If aspirin reduces the risk of dying of 
heart disease by 10% (for example from 25% to 22.5%), take-up would increase by 0.6 percentage points. The risk of 
heart disease is associated with lower use of aspirin, perhaps due to the fact that those already taking aspirin perceive 
their risks to be lowered.  Men are more likely to use aspirin, as are those with high cholesterol.  Other coefficients 
are insignificant. 
Table 8B considers preventive interventions offered only to subsets of the population.  The first two 
columns consider mammograms and Pap smears.  The third column considers tests for sexually transmitted diseases 
(STD).  In all three cases, the perceived effectiveness of the intervention in reducing the risk of death increases the 
take-up of the intervention. If mammograms are perceived to change the probability of dying of breast cancer by 
10%, take-up would increase by 0.3 percentage points.  For Pap smears and STD tests the effect is 1 percentage 
points. The effect of invitations on mammogram and Pap smear take up is very large, increasing take-up by 75 and 
71 percentage points, respectively.  For STD tests, invitations increase take up by 47 percentage points.  Numeracy 
and family history of breast cancer increase the take up of mammograms.  For STD tests, men are 11 percentage 
points less likely to have undergone a test and those with a college degree are 11 percentage points more likely to 
have undergone a test. 
It is also interesting to consider the effects of risk perceptions among subgroups of the population.
14  
Because invitations play such an important role in the decision to use preventive care and because invitations are 
targeted based on underlying risk, it is possible that risk perceptions, invitations, and true risk are highly correlated.  
To address this possibility, we consider the effects of risk perceptions in four distinct population subgroups: those 65 
and over who receive an invitation, those 65 and over who do not receive an invitation, those under 65 who receive 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
13 Although higher opportunity costs of time would also increase the cost of illness, should it occur, these may be 
outweighed by the costs of time to receive a flu shot.  This is especially true because flu shots are typically only 
available at the GPs office, or very occasionally at the place of employment. 
14 These results are available in Appendix Table 2. 16 
an invitation and those under 65 who do not receive an invitation.
15  We find that for all age groups and invitation 
combinations, risk perceptions and perceptions of effectiveness affect take up of the flu shot.   
Table 9, considers the effect of both subjective and epidemiological probabilities on take up of preventive 
care.  Column 1 and 2 consider the use of flu shots; a 10 percentage point increase in the perceived probability of 
getting influenza increases take up by 2.2 or 2.3 percentage points, for 2007 and 2008 respectively.  If we consider 
the perceived risk of death from influenza, the effects are 0.7 or 0.6 percentage points respectively.  The 
epidemiological risk of death is significant in 2007 but not in 2008, due to changes in eligibility for flu shots, as 
discussed in section 2.  The coefficients on the epidemiological risk are large, however this reflects the size of the 
underlying risk which is on average less than 0.03 percent and the huge success of the government influenza shot 
program.
16 For mammograms, after controlling for age and the government invitation, epidemiological probabilities 
have no effect on take up.  Perceived risks of breast cancer do continue to have an effect on take up; cancer 10 
percentage point increase in perceived risk increases take-up by 0.8 percentage points.  For heart disease and the use 
of aspirin, only the epidemiological probabilities matter, perhaps because they are closely aligned with expert advice.  
An individual with a high risk of heart disease is more likely to have their doctor recommend the use of aspirin.  The 
perceived risk has no additional effect on take up of aspirin.  The difference between this result and others may be 
that controlling for the invitations for flu shots and mammograms may control for the underlying epidemiological 
risk.  In the case of the use of aspirin for the prevention of heart disease, we have no similar control. 
In standard economic models of decisions regarding preventive interventions, information on risk factors 
plays a role through the probabilities of getting the disease or dying from it with and without the intervention. Once 
these probabilities are known, the risk factors should not play an additional role in the take-up decision. Still, one 
might ask whether an exogenous change in perceived probabilities, leaving all observed and unobserved risk factors 
unchanged, will affect the take-up of preventive interventions. Such an exogenous change could result from the 
receipt of a letter with numerical probability information. Although we lack the ideal instrumental variables in our 
data set to answer this question, we have performed a number of IV estimations in the flu shot analysis. As 
instruments we used a) whether any individual in the respondent’s household had received a flu shot invitation from 
an employer, and b) whether any individual in the respondent’s household had received a flu shot invitation from a 
doctor. The second stage regressions shows diminished importance of perceived probabilities in explaining take-up; 
however, the first stage regressions indicate that the instruments are weak.     
 
￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿￿
15 Everyone over the age of 65 should receive an invitation for a flu shot, however, some (12%) report not being 
invited.  This may be due to clerical error, poor memory, or simply a failure to open their mail.  For those under the 
age of 65: some receive invitations from their physician because they are at high risk, others receive invitations from 
their employer or other sources. 
16 Because influenza risk is determined by age only and because the flu shot invitations are also mostly determined 
by age groups, we include age and age squared rather than 5 year age groups.  Thus the epidemiological risk captures 
the non-linearities in take up with respect to age. 17 
7.  Conclusion 
This paper uses unique data measuring individuals’ risk perceptions across multiple diseases to examine the 
relationship between individual risk perceptions, epidemiological measures of risk, and use of preventive care.  We 
have three main findings.  First, we find that on average individuals are aware of only some of the qualitative 
relationships between risk factors and their risk.  Second, they vastly, and systematically, overestimate their risk of 
disease.  Third, despite this overestimation and in some cases lack of awareness of risk factors, perceptions of risk 
play an important role in the decision to use preventive care.  Those who perceive that they face more risk of disease 
and death are more likely to use preventive care, as are those who perceive prevention to be more effective.  We tend 
to see no effect among those who think that the intervention will actually increase their risk of disease or death, 
except with the flu shot.  For the flu, those who perceive the flu shot to increase their risk are less likely to take-up 
the intervention.  This difference may stem from a misunderstanding of vaccines; a causal link between receiving a 
flu shot and an increased risk of influenza may be more plausible than a similar link between Pap smears and cancer.  
The perceived risk of death is only significant for flu shots and the use of aspirin, and the coefficients are remarkably 
similar.   
Risk perceptions are significant predictors of the use of preventive care, even when we control for 
individually predicted epidemiological risks.  There are several reasons why risk perceptions are likely to have an 
effect on behavior even after controlling for epidemiological risks.  First, individuals may know more about their 
own situation than is captured in these epidemiological models, and thus risk perceptions would contain more 
information about true risks.  Second, while epidemiological models may more closely estimate true risks, we would 
expect individuals to base their choices on their beliefs and not necessarily on potentially unknown true values. The 
dramatic overestimation of risk and the fact that individuals are not aware of many important risk factors, suggest 
that the former, on average is not the case.  Instead the relationship between perceptions and behavior suggests that 
those who perceive greater risks are more likely to take action to reduce risks. 
Individuals’ perceptions of risk and effectiveness are often far from the epidemiologically predicted values, 
thus interventions to encourage use of preventive care should be designed carefully.  If information focuses only on 
the underlying risk of disease, that could actually reduce the use of prevention since many perceive risks to be greater 
than they actually are.  However, accurate information about the effectiveness of prevention could increase the use of 
preventive care.  In particular, it is not uncommon for people to believe that preventive interventions will actually 
increase their risks.  More accurate information about effectiveness could encourage especially those individuals to 
participate in preventive interventions. 
In principle, the preventive health care choices considered here offer an opportunity to measure individual' s 
willingness to pay for risk reductions on the basis of revealed preferences. Viscusi and Aldy (2003) provide a review 
of the literature on willingness to pay to reduce the risk of death.  For example, suppose we observe a person who 
does not have a flu shot at age 59 (just below the free flu shot eligibility age) and does have a flu shot at age 60 (free 
flu shot). All else equal, this would allow us to estimate an upper and a lower bound for the person' s willingness to 
pay for this particular risk reduction. Implementing such a procedure, however, is a road covered with pitfalls. First, 
the all else equal condition requires controlling for a large number of factors (like the amount of information 
available, spouse' s health and behavior, the flu incidence in the population, and the opportunity costs of time). 18 
Secondly, the lion' s share of the personal costs of getting the flu are not the risk of death but the disutility from being 
ill and absent from work. Finally, deviations from rationality like hyperbolic discounting and other time-inconsistent 
preferences, prohibit a meaningful interpretation of the outcomes of such an exercise.  
Our results indicate that written invitations for flu shots, mammograms, and Pap smears in the Netherlands 
strongly increased the likelihood of participation. One topic for future research is how information provision can be 
used more effectively through a careful design of information on risk and effectiveness, both in terms of 
(quantitative) content and in terms of framing.  19 
Table 1: Descriptive Statistics 
Variable  Obs  Mean  Std. Dev. 
Male  5687  0.460  0.498 
Age  5687  47.281  15.451 
Net household income  5686  3034  8289 
Education level:  5686     
Did not finish 2ndary education  502  0.088   
2ndary education  2132  0.375   
MBO (similar to Associates degree)  1344  0.236   
HBO or WO (Bachelors degree or higher)  1708  0.300   
Received a flu shot in 2007  5687  0.226  0.418 
Received a flu shot in 2008  4693  0.287  0.452 
Had a mammogram in last 2 years  3072  0.394  0.489 
Had a Pap smear in last 5 years  3072  0.605  0.489 
Have used the kidney check  1404  0.237  0.426 




Table 2: Annual Influenza Associated Mortality Rates per 100,000 People by Age 
Age  Conservative Measure: 
Underlying Pneumonia 
and Influenza Deaths 
Moderate Measure: 
Underlying Respiratory 
and Circulatory Deaths 
Liberal Measure: All-
Cause Deaths 
Perception of Risk of 
Mortality  
5 to 49  0.2  0.5  1.5  10,032 
50 to 64  1.3  7.5  12.5  13,845 
65 plus  22.1  98.3  132.5  24,176 
Note: Columns 1 through 3 from Table 5 of Thompson et al. (2003). Based on death due to influenza from the 1990-
1991 through 1998-1999 seasons. Column 4 is from our own calculations. 20 
 
Table 3: Subjective and Epidemiological Probabilities of Getting a Disease (percentages) 




Mean  Standard 
dev 
Min  Median  Max 
Influenza  1 year  Subj w/ flu shot  19.59%  21.49%  0  10.11%  100% 
  Epid w/flu shot  -  -  -  -  - 
  Subj w/o flu shot  30.95%  26.69%  0  20.64%  100% 
  Epid w/o flu shot  -  -  -  -  - 
  Subj Effectiveness 
(pwo-pw) /pwo 
-303%  14042%  -999900%  33.33%  100% 
  Epid           
               
Breast 
Cancer 
5 year  Subj  19.131%  19.186%  0%  10.145%  100% 
  Epid  0.865%  0.740%  0.003%  0.796%  3.642% 
10 year  Subj  21.626%  19.812%  0%  14.465%  100% 
  Epid  1.918%  1.490%  0.009%  1.769%  7.137% 
               
Cervical 
Cancer 
5 year  Subj  13.71%  17.28%  0%  6.65%  100% 
  Epid  <1%  -  -  -  - 
10 year  Subj  15.20%  17.69%  0%  9.86%  100% 
  Epid  <1%  -  -  -  - 




5 year  Subj  7.40%  12.93%  0%  1.83%  99.3% 
  Epid    -  -  -  - 
10 year  Subj  8.19%  13.56%  0%  2.44%  98.38% 
  Epid    -  -  -  - 
               
Aids  5 year  Subj  3.78%  9.34%  0%  0.93  99.99 
  Epid    -  -  -  - 
10 year  Subj  4.03%  9.25%  0%  1  99.76 
  Epid    -  -  -  - 
               
Heart 
Disease 
5 year  Subj  16.40%  18.42%  0%  10%  100% 
  Epid  6.40%  5.91%  1%  4%  47% 
10 year  Subj  19.52%  19.83%  0%  10.32%  100% 
  Epid  12.80%  11.81%  2%  8%  94% 
 21 
Table 4: Subjective and Epidemiological Probabilities of Dying (percentages) 
Table 4A: Subjective and Epidemiological Probabilities of Influenza Related Death 
Time 
Period 
Prevention  Subj/Epid 
probability 
Mean  Stan. 
Dev 
Min  Median  Max 
1 year  With flu shot  Subj  11.14%  23.35%  0%  1.1500%  100% 
  Epid- mod  0.006%  0.014%  0.0001%  0.0001%  0.0398% 
               
  Without flu shot  Subj  13.24%  23.96%  0%  2%  100% 
  Epid- mod  0.032%  0.068%  0.0006%  0.0006%  0.1988% 
               
  Effectiveness of flu 
shot (pwo-pw)/pwo 
Subj  -105%  1942%  -75755%  1.393%  100% 
  Epid  80%         
 
Table 4B: Subjective and Epidemiological Probabilities of Death from Breast Cancer 
Time 
Period 
Prevention  Subj/Epid 
probability 
Mean  Stan. 
Dev 
Min  Median  Max 
10 year  With mammogram  Subj  15.80%  18.06%  0%  10%  100% 
  Epid  0.195%  0.149%  0.001%  0.180%  0.792% 
               
  Without mammogram  Subj  26.36%  23.66%  0%  20%  100% 
  Epid  0.229%  0.176%  0.001%  0.211%  0.931% 
               
  Effectiveness of mamm 
(pwo-pw)/pwo 
Subj  12.17%  459.%  -16485%  43.24%  100% 
  Epid  15%         
20 year  With mammogram  Subj  17.34%  18.21%  0%  10.09%  100% 
  Epid  0.279%  0.155%  0.015%  0.267%  0.903% 
               
  Without mammogram  Subj  28.85%  24.56%  0%  20.41%  100% 
  Epid  0.328%  0.183%  0.017%  0.314%  1.062% 
               
  Effectiveness of mamm 
(pwo-pw)/pwo 
Subj  16.77%  439%  -19229%  38.71%  100% 
  Epid  15%         
 
 Table 4C: Subjective Probabilities of Death from Heart Disease 
Time 
Period 
Prevention  Subj/Epid 
probability 
Mean  Stan. 
Dev 
Min  Median  Max 
10 year  With aspirin  Subj  16.61%  19.00%  0%  10%  100% 
    Epid  0.493%  0.468%  0.068%  0.408%  3.196% 
               
  Without aspirin  Subj  19.68%  21.52%  0%  10.09%  100% 
    Epid  0.725%  0.688%  0.1%  0.6%  4.7% 
               
  Effectiveness of aspirin 
(pwo-pw)/pwo 
Subj  -6%  341%  -13700%  1%%  100% 
  Epid           
20 year  With aspirin  Subj  20.08%  21.14%  0%  10.32%  100% 
    Epid  4.930%  4.679%  0.68%  4.08%  31.96% 
               
  Without aspirin  Subj  23.78%  23.75%  0%  15%  100% 
    Epid  7.250%  6.881%  1%  6%  47% 
               
  Effectiveness of aspirin 
(pwo-pw)/pwo 
Subj  -18%  1388%  -99900%  2%  100% 
  Epid           22 
Table 5: Relationship between Risk Factors and Perceived or Epidemiological Risks 
Table 5A: 5 year Risk of Breast Cancer  
  Ln of Epid. predicted risk   Ln of perceived risk  
Biopsy required and age 50+  0.241  0.429 
  ￿  (0.561) 
Biopsy required and age less than 50  0.529  -0.143 
  ￿  (0.535) 
Age of first birth 20-24, no family history of cancer  0.218  0.438 
  ￿  (0.360) 
Age of first birth 25-29/ no children, no family history of cancer  0.437  0.498 
  ￿  (0.351) 
Age of first birth 30+, no family history of cancer  0.656  0.393 
  ￿  (0.359) 
Age of first birth 19 or less, family history of cancer  0.958  0.214 
  ￿  (0.979) 
Age of first birth 20-24, family history of cancer  0.986  0.612 
  ￿  (0.453) 
Age of first birth 25-29/ no children, family history of cancer  1.014  1.234*** 
  ￿  (0.394) 
Age of first birth 30+, family history of cancer  1.042  1.156*** 
  ￿  (0.441) 
Age 25-29  1.992  0.026 
  ￿  (0.226) 
Age 30-34  3.245  0.471** 
  ￿  (0.210) 
Age 35-39  4.154  0.471** 
  ￿  (0.204) 
Age 40-44  4.804  0.529*** 
  ￿  (0.203) 
Age 45-49  5.193  0.563*** 
  ￿  (0.199) 
Age 50-54  5.363  0.228 
  ￿  (0.204) 
Age 55-59  5.571  0.220 
  ￿  (0.210) 
Age 60-64  5.778  0.218 
  ￿  (0.222) 
Age 65-69  5.936  0.368 
  ￿  (0.239) 
Age 70-74  5.999  -0.213 
  ￿  (0.302) 
Age 75-79  6.056  -1.132** 
  ￿  (0.501) 
Age 80+  6.060  -0.123 
  ￿  (0.336) 
Constant  -10.414  1.071*** 
  ￿  (0.377) 
Observations  3,072  2,976 
R-squared  1.000  0.018 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.   23 
 
Table 5B: 5 year Risk of Heart Disease among Women 
  Ln of Epid. predicted risk   Ln of perceived risk  
     
Age Points  0.134***  0.062*** 
  (0.001)  (0.007) 
Blood Pressure Points  0.155***  0.188*** 
  (0.005)  (0.055) 
Cholesterol Points  0.178***  0.362*** 
  (0.011)  (0.131) 
Diabetes Points  0.154***  0.099* 
  (0.004)  (0.052) 
Smoking Points  0.114***  0.083 
  (0.005)  (0.060) 
Constant  0.921***  1.317*** 
  (0.005)  (0.059) 
Observations  3072  2853 
R-squared  0.952  0.049 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.   
 
Table 5C: 5 year Risk of Heart Disease among Men 
  Ln of Epid. predicted risk   Ln of perceived risk  
     
Age Points  0.232***  0.241*** 
  (0.001)  (0.022) 
Blood Pressure Points  0.230***  0.185*** 
  (0.002)  (0.063) 
Cholesterol Points  0.221***  0.117 
  (0.003)  (0.125) 
Diabetes Points  0.218***  0.060 
  (0.003)  (0.114) 
Smoking Points  0.242***  0.068 
  (0.002)  (0.062) 
Constant  1.024***  0.951*** 
  (0.002)  (0.076) 
Observations  2615  2288 
R-squared  0.992  0.074 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.   24 
Table 6 OLS Regressions Predicting Perceived risk 
VARIABLES 
Perceived Risk 




Disease in 5 yrs 
Perceived Risk 
of Breast 
Cancer in 5 yrs  
       
Dummy if Male  0.003  0.011**   
  (0.007)  (0.005)   
Age 25-29  -0.013  0.023  0.008 
  (0.018)  (0.014)  (0.020) 
Age 30-34  0.001  0.022*  0.062*** 
  (0.016)  (0.013)  (0.018) 
Age 35-39  -0.019  0.036***  0.033* 
  (0.016)  (0.012)  (0.017) 
Age 40-44  0.005  0.070***  0.051*** 
  (0.015)  (0.012)  (0.017) 
Age 45-49  -0.009  0.079***  0.048*** 
  (0.015)  (0.012)  (0.017) 
Age 50-54  0.002  0.082***  0.031 
  (0.016)  (0.012)  (0.021) 
Age 55-59  0.018  0.091***  0.015 
  (0.016)  (0.012)  (0.022) 
Age 60-64  0.030*  0.113***  0.025 
  (0.016)  (0.013)  (0.023) 
Age 65-69  0.054***  0.106***  0.010 
  (0.018)  (0.014)  (0.024) 
Age 70-74  0.083***  0.132***  0.011 
  (0.021)  (0.018)  (0.028) 
Age 75-79  0.183***  0.140***  0.003 
  (0.025)  (0.022)  (0.030) 
Age 80-84  0.167***  0.095***  -0.002 
  (0.035)  (0.030)  (0.047) 
Age 85-92  0.143**  0.067  -0.078 
  (0.065)  (0.062)  (0.078) 
Received invitation  0.021**    0.019 
  (0.008)    (0.014) 
Self Assessed Health is Good or better  -0.016**  -0.046***  -0.031*** 
  (0.008)  (0.006)  (0.009) 
Diagnosed with Heart Disease  0.024**    -0.004 
  (0.012)    (0.015) 
Diagnosed with Diabetes  0.012  0.016  0.018 
  (0.014)  (0.012)  (0.016) 
Diagnosed with High Blood Pressure  0.007  0.032***  0.013 
  (0.009)  (0.007)  (0.010) 
Diagnosed with High Cholesterol  -0.007  0.036***  -0.012 
  (0.010)  (0.008)  (0.012) 
Dummy if Smoker  -0.003  0.020***  -0.000 
  (0.008)  (0.006)  (0.009) 
BMI  0.0009**  0.0006*  0.0001 
  (.0004)  (0.0003)  (0.0004) 
Breast Cancer in Family      0.113*** 
      (0.025) 25 
Previous Breast Biopsy      0.037 
      (0.062) 
Age of First Live Birth      -0.028 
      (0.018) 
ln(net household income)  0.000  -0.014***  -0.005 
  (0.006)  (0.005)  (0.007) 
Numeracy  -0.135***  -0.030**  -0.025 
  (0.015)  (0.012)  (0.017) 
Did not finish 2ndary education  0.010  -0.027***  -0.034** 
  (0.013)  (0.010)  (0.014) 
MBO (similar to Associates degree)  -0.020**  0.011  0.009 
  (0.009)  (0.007)  (0.010) 
HBO or WO (Bachelors degree or higher)  -0.020**  -0.008  -0.012 
  (0.009)  (0.007)  (0.010) 
Dummy if Magnifier scale  0.017**  0.032***  0.050*** 
  (0.008)  (0.006)  (0.009) 
Dummy if Linear  0.021***  0.035***  0.048*** 
  (0.008)  (0.006)  (0.009) 
Constant  0.182***  0.188***  0.183** 
  (0.050)  (0.040)  (0.085) 
Observations  4922  4448  2563 
R-squared  0.084  0.115  0.058 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.   26 











and One  
Dummy if Male  0.042**  0.076***     
  (0.019)  (0.008)     
ln(net household income)  0.000  0.017**  -0.004  0.013 
  (0.018)  (0.008)  (0.018)  (0.009) 
Numeracy  0.205***  0.045**  0.199***  0.060** 
  (0.044)  (0.019)  (0.047)  (0.024) 
Did not finish 2ndary education  0.015  0.007  0.081**  0.021 
  (0.036)  (0.015)  (0.039)  (0.020) 
MBO (similar to Associates degree)  -0.002  -0.023**  -0.007  -0.023 
  (0.026)  (0.011)  (0.029)  (0.014) 
HBO or WO (Bachelors degree or higher)  0.036  0.007  0.036  0.012 
  (0.025)  (0.010)  (0.028)  (0.014) 
Self Assessed Health is Excellent or Good  0.087***  0.054***  0.096***  0.054*** 
  (0.023)  (0.009)  (0.026)  (0.012) 
Dummy if Magnifier scale  -0.129***  -0.067***  -0.125***  -0.071*** 
  (0.023)  (0.010)  (0.026)  (0.013) 
Dummy if Linear  -0.160***  -0.098***  -0.167***  -0.110*** 
  (0.023)  (0.010)  (0.026)  (0.012) 
Flu Shot Invitation  -0.054**  -0.023**  0.003  -0.005 
  (0.024)  (0.010)  (0.026)  (0.012) 
Mammogram invitation      -0.029  -0.024 
      (0.038)  (0.019) 
Pap Smear invitation      -0.075**  -0.003 
      (0.031)  (0.015) 
Diagnosed with Diabetes  -0.047  -0.015  -0.088*  -0.038* 
  (0.039)  (0.016)  (0.046)  (0.023) 
Diagnosed with High Blood Pressure  -0.057**  -0.029***  -0.049*  -0.029** 
  (0.025)  (0.010)  (0.028)  (0.014) 
Diagnosed with High Cholesterol  -0.038  -0.024**  -0.022  -0.001 
  (0.028)  (0.012)  (0.034)  (0.017) 
Dummy if Smoker  -0.025  -0.006  -0.008  0.004 
  (0.023)  (0.010)  (0.026)  (0.013) 
BMI  -0.0010  -0.0002  -0.0003  -0.0002 
  (0.0011)  (0.0005)  (0.0011)  (0.0005) 
Breast Cancer in Family      -0.035  -0.021 
      (0.034)  (0.017) 
Constant  0.460***  0.399***  0.432***  0.389*** 
  (0.145)  (0.062)  (0.151)  (0.077) 
Observations  4922  3737  2645  2104 
R-squared  0.047  0.098  0.048  0.071 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.  Regressions also control for 5 year age 
groups, and dummies for visual scales. 27 
Table 8A: OLS Regressions Predicting Use of Preventive Care: Whole Sample 
Dependent Variable 
Flu Shot in 
2007 (before 
survey) 







Subjective effectiveness at preventing disease: (pwo-
pw)/pwo, if effectiveness is positive 
0.1579***  0.1375***   
(0.0121)  (0.0157)   
Dummy if subjective effectiveness of preventing disease is 
negative  
-0.0126  -0.0365***   
(0.0110)  (0.0142)   
Subjective probability of Getting Disease without 
intervention 
0.1421***  0.1438***   
(0.0144)  (0.0188)   
Subjective probability of Getting Disease      -0.0571*** 
      (0.0172) 
Subjective effectiveness at preventing death: (pwo-
pw)/pwo, if effectiveness is positive 
0.0939***  0.1116***  0.0580*** 
(0.0119)  (0.0155)  (0.0080) 
Dummy if subjective effectives of preventing death is 
negative  
-0.0237**  -0.0108  0.0026 
(0.0097)  (0.0126)  (0.0048) 
Subjective probability of Dying (in 10 year for all but flu 
shot) without intervention 
0.0718***  0.0679***  0.0829*** 
(0.0155)  (0.0203)  (0.0172) 
Received invitation for intervention  0.4349***  0.3170***   
  (0.0094)  (0.0123)   
Expected or Actual monetary cost of intervention  -0.0014***  -0.0010***   
  (0.0001)  (0.0002)   
Expected or Actual time cost of intervention  -0.0008***  -0.0008***   
  (0.0001)  (0.0002)   
Dummy if Male  0.0111  0.0021  0.0137*** 
  (0.0073)  (0.0095)  (0.0037) 
ln(net household income)  0.0059  -0.0041  -0.0003 
  (0.0066)  (0.0086)  (0.0033) 
Numeracy  -0.0382**  -0.0209  -0.0018 
  (0.0168)  (0.0219)  (0.0084) 
Did not finish 2ndary education  -0.0010  0.0123  -0.0041 
  (0.0135)  (0.0172)  (0.0070) 
MBO (similar to Associates degree)  -0.0142  -0.0190  0.0002 
  (0.0097)  (0.0126)  (0.0049) 
HBO or WO (Bachelors degree or higher)  -0.0329***  -0.0153  0.0041 
  (0.0093)  (0.0121)  (0.0047) 
Dummy if has Diabetes  0.0983***  0.0949***  0.0029 
  (0.0144)  (0.0185)  (0.0079) 
Dummy if has Heart Disease  0.0876***  0.0534***   
  (0.0129)  (0.0162)   
Dummy if has High Blood Pressure  0.0230**  0.0253**  0.0047 
  (0.0092)  (0.0118)  (0.0049) 
Dummy if has High Cholesterol      0.0181*** 
      (0.0058) 
Dummy if Smoker      0.0077* 
      (0.0044) 
BMI      0.0000 
      (0.0002) 28 
Self Assessed Health is Excellent or Good  -0.0249***  -0.0346***  0.0025 
  (0.0084)  (0.0109)  (0.0042) 
Dummy if friends have died of disease  0.0636***  0.0530*  0.0023 
  (0.0244)  (0.0312)  (0.0037) 
Constant  -0.0657  0.0037  -0.0197 
  (0.0540)  (0.0700)  (0.0271) 
Observations  4927  4313  4448 
R-squared  0.658  0.570  0.061 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.  Regressions also control for 5 year age 
groups. 29 
Table 8B: OLS Regressions Predicting Use of Preventive Care: Sample to Relevant Demographic Groups 
Dependent Variable 
Mammogram 
in last 2 years 
Pap Smear in 




Disease in Past 
Sample  Women  Women 
Younger than 
40 
Subjective probability of Getting Disease 
 
0.0568  0.0822  0.1152 
(0.0370)  (0.0558)  (0.0959) 
Subjective effectiveness at preventing death: (pwo-
pw)/pwo, if effectiveness is positive 
0.0337*  0.0969***  0.0984** 
(0.0176)  (0.0207)  (0.0405) 
Dummy if subjective effectives of preventing death is 
negative  
0.0169  -0.0058  0.0031 
(0.0172)  (0.0195)  (0.0334) 
Subjective probability of Dying (in 10 year for all but flu 
shot) without intervention 
0.0320  0.0488  -0.0054 
(0.0323)  (0.0473)  (0.0812) 
Received invitation for intervention 
 
0.7505***  0.7100***  0.4718*** 
(0.0188)  (0.0174)  (0.0939) 
Expected or Actual monetary cost of intervention  -0.0004***  -0.0017***  -0.0026*** 
  (0.0001)  (0.0001)  (0.0002) 
Expected or Actual time cost of intervention 
 
-0.0001  0.0002  0.0008*** 
(0.0001)  (0.0002)  (0.0002) 
Dummy if Male      -0.1118*** 
      (0.0240) 
ln(net household income)  0.0091  0.0133  -0.0193 
  (0.0088)  (0.0100)  (0.0193) 
Numeracy  0.0711***  0.0258  -0.0590 
  (0.0229)  (0.0259)  (0.0571) 
Did not finish 2ndary education  0.0087  0.0038  -0.0203 
  (0.0188)  (0.0214)  (0.0530) 
MBO (similar to Associates degree)  0.0126  0.0056  0.0087 
  (0.0136)  (0.0156)  (0.0307) 
HBO or WO (Bachelors degree or higher)  0.0189  -0.0162  0.1149*** 
  (0.0132)  (0.0151)  (0.0320) 
Dummy if has Diabetes  -0.0362*  -0.0464*  -0.0341 
  (0.0215)  (0.0242)  (0.0859) 
Dummy if has Heart Disease  0.0060  -0.0057  0.1463* 
  (0.0199)  (0.0229)  (0.0841) 
Self Assessed Health Excellent or Good  0.0062  0.0084  -0.0088 
  (0.0119)  (0.0136)  (0.0243) 
Dummy if Family Member had disease  0.0351**  -0.0358   
  (0.0165)  (0.0325)   
Dummy if friends have died of disease  0.0098  0.0135  0.0063 
  (0.0107)  (0.0199)  (0.0931) 
Constant  -0.1282*  -0.0494  0.3954** 
  (0.0718)  (0.0812)  (0.1589) 
Observations  2567  2578  1176 
R-squared  0.742  0.662  0.194 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.  Regressions also control for 5 year age 
groups. 30 
Table 9: OLS Regressions Predicting Use of Preventive Care: Comparing the Role of Subjective and Objective 
Probabilities 
Dependent Variable 
Flu Shot in 
2007 (before 
survey) 
















Subjective Probability of Flu without flu shot  0.2170***  0.2278***     
  (0.0143)  (0.0191)     
Epidemiological Probability of Death from 
Flu without flu shot 
48.5852***  -17.5050     
(10.0416)  (12.8396)     
Subjective Probability of Death from Flu 
without flu shot 
0.0693***  0.0620***     
(0.0160)  (0.0213)     
Subjective Probability of Disease in 10 years      0.0798***  0.0030 
      (0.0255)  (0.0096) 
Epidemiological Probability of Disease in 10 
years 
    -0.9776  0.2146*** 
    (1.1401)  (0.0342) 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.  Regressions also control for 5 year age 
groups (age and age squared for flu shots), invitations, expected or actual costs, male, household income, numeracy, 
education dummies, and health indicators. 
 31 
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Appendix Table 1: Subjective Probability Questions 
What is the percent chance that... 
Flu 
You will get the flu in the winter, if you get a flu shot this fall? 
You will get the flu in the winter, if you don’t get a flu shot this fall? 
You will get the flu and (survive/die), if you get a flu shot this fall? 
You will get the flu and (survive/die) if you don’t get a flu shot this fall? 
Breast cancer (if female) 
You will get breast cancer in the next 5 years? 
You will get breast cancer in the next 10 years? 
You will get breast cancer and die from it in the next 10 years, if you get a mammogram every 2 years? 
You will get breast cancer and die from it in the next 10 years, if you don’t get any mammograms? 
You will get breast cancer and die from it in the next 20 years, if you get a mammogram every 2 years? 
You will get breast cancer and die from it in the next 20 years, if you don’t get any mammograms? 
Cervical cancer (if female) 
You will get cervical cancer in the next 5 years? 
You will get cervical cancer in the next 10 years? 
You will get cervical cancer and die from it in the next 10 years, if you get a Pap smear every 5 years? 
You will get cervical cancer and die from it in the next 10 years, if you don’t get any Pap smears? 
You will get cervical cancer and die from it in the next 20 years, if you get a Pap smear every 5 years? 
You will get cervical cancer and die from it in the next 20 years, if you don’t get any Pap smears? 
Sexually transmitted infections (if under 40) 
You will get an/another STD in the next 5 years? 
You will get an/another STD in the next 10 years? 
You will get AIDS and die from it in the next 10 years, if you get an STD test every year? 
You will get AIDS and die from it in the next 10 years, if you don’t get an STD test? 
You will get AIDS and die from it in the next 20 years, if you get an STD test every year? 
You will get AIDS and die from it in the next 20 years, if you don’t get an STD test? 
Heart disease 
You will get heart disease in the next 5 years? 
You will get heart disease in the next 10 years? 
You will get heart disease and die from it in the next 10 years, if you take a low dose of aspirin every day (or 
every other day) to reduce your risk? 
You will get heart disease and die from it in the next 10 years, if you don’t take a low dose of aspirin every day 
(or every other day) to reduce your risk? 
You will get heart disease and die from it in the next 20 years, if you take a low dose of aspirin every day (or 
every other day) to reduce your risk? 
You will get heart disease and die from it in the next 20 years, if you don’t take a low dose of aspirin every day 
(or every other day) to reduce your risk? 
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Appendix Table 2: OLS Regressions Predicting Use of Flu Shots by Subgroups 
Dependent Variable 
Full Sample  65 + & invited 
65 + & not 
invited 
<65 & invited 
<65 & not 
invited 
Subjective effectiveness at preventing disease: (pwo-pw)/pwo, if 
effectiveness is positive 
0.1579***  0.3301***  0.4853***  0.3631***  0.0139*** 
(0.0121)  (0.0461)  (0.1126)  (0.0417)  (0.0053) 
Dummy if subjective effectiveness of preventing disease is 
negative  
-0.0126  -0.0935**  0.0370  0.0260  0.0017 
(0.0110)  (0.0462)  (0.0908)  (0.0381)  (0.0047) 
Subjective probability of Getting Disease without intervention  0.1421***  0.1107**  0.1333  0.3136***  0.0278*** 
(0.0144)  (0.0522)  (0.1837)  (0.0473)  (0.0064) 
Subjective effectiveness at preventing death: (pwo-pw)/pwo, if 
effectiveness is positive 
0.0939***  0.1025***  -0.0670  0.1025***  0.0103* 
(0.0119)  (0.0389)  (0.1037)  (0.0364)  (0.0057) 
Dummy if subjective effectives of preventing death is negative   -0.0237**  -0.0403  -0.0086  -0.0449  -0.0007 
(0.0097)  (0.0392)  (0.0960)  (0.0334)  (0.0042) 
Subjective probability of Dying (in 10 year for all but flu shot) 
without intervention 
0.0718***  0.0645  0.0307  0.1174**  -0.0002 
(0.0155)  (0.0478)  (0.1523)  (0.0513)  (0.0073) 
Received invitation for intervention  0.4349***         
  (0.0094)         
Expected or Actual monetary cost of intervention  -0.0014***  -0.0038***  -0.0023  -0.0063***  -0.0001* 
  (0.0001)  (0.0006)  (0.0020)  (0.0006)  (0.0001) 
Expected or Actual time cost of intervention  -0.0008***  -0.0038***  -0.0017  -0.0027***  -0.0001 
  (0.0001)  (0.0010)  (0.0017)  (0.0006)  (0.0001) 
Dummy if Male  0.0111  0.0092  0.0225  0.0069  -0.0007 
  (0.0073)  (0.0260)  (0.0691)  (0.0242)  (0.0033) 
ln(net household income)  0.0059  0.0063  0.0934  0.0005  0.0036 
  (0.0066)  (0.0268)  (0.0879)  (0.0217)  (0.0029) 
Numeracy  -0.0382**  0.0083  -0.0648  -0.1692***  0.0012 
  (0.0168)  (0.0541)  (0.1466)  (0.0528)  (0.0078) 
Did not finish 2ndary education  -0.0010  0.0662**  -0.0403  -0.0769*  -0.0079 
  (0.0135)  (0.0335)  (0.1083)  (0.0445)  (0.0068) 
MBO (similar to Associates degree)  -0.0142  0.1006**  -0.1446  -0.0841***  0.0034 
  (0.0097)  (0.0406)  (0.0962)  (0.0315)  (0.0042) 
HBO or WO (Bachelors degree or higher)  -0.0329***  0.0268  -0.1105  -0.1178***  0.0064 
  (0.0093)  (0.0327)  (0.0781)  (0.0314)  (0.0042) 34 
Dummy if has Diabetes  0.0983***  0.0006  0.0299  0.1336***  -0.0002 
  (0.0144)  (0.0330)  (0.1191)  (0.0341)  (0.0103) 
Dummy if has Heart Disease  0.0876***  0.0768***  0.0589  0.0932***  -0.0056 
  (0.0129)  (0.0284)  (0.0795)  (0.0337)  (0.0089) 
Dummy if has High Blood Pressure  0.0230**  0.0581**  0.0998  0.0056  0.0075 
  (0.0092)  (0.0255)  (0.0662)  (0.0276)  (0.0046) 
Self Assessed Health is Excellent or Good  -0.0249***  -0.0544  -0.0883  -0.0764**  -0.0022 
  (0.0084)  (0.0345)  (0.0755)  (0.0307)  (0.0036) 
Dummy if friends have died of disease  0.0636***  -0.0160  0.1917  0.1822***  -0.0103 
  (0.0244)  (0.0612)  (0.3636)  (0.0652)  (0.0134) 
Constant  -0.0657  0.5552***  -0.9540  0.3925**  -0.0346 
  (0.0540)  (0.2142)  (0.7157)  (0.1801)  (0.0236) 
Percent Receiving flu shot  23%  82%  9%  55%  1% 
Observations  4927  646  91  1010  3180 
R-squared  0.658  0.373  0.420  0.480  0.027 
Notes: Standard errors in parentheses, *** p<0.01, ** p<0.05, * p<0.1.  Regressions also control for 5 year age groups. 35 
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